Franklin Resources
KYNB

Franklin Resources’s Kyntra Bio KYNB Stock Holding History

Franklin Resources’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-23,064
Closed -$12.3M – 1512
2016
Q1 		$12.3M Hold
23,064
– – 0.01% 927
2015
Q4 		$17.6M Sell
23,064
-10,988
-32% -$7.29M 0.01% 877
2015
Q3 		$18.7M Sell
34,052
-35,635
-51% -$21.6M 0.01% 868
2015
Q2 		$40.9M Buy
69,687
+53,687
+336% +$31.2M 0.02% 674
2015
Q1 		$12.6M Hold
16,000
– – 0.01% 997
2014
Q4 		$10.9M Buy
+16,000
New +$10.3M 0.01% 1032

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources's KYNB Position: Q2 2016 in Review

Franklin Resources sold out of Kyntra Bio (KYNB) in Q2 2016, closing a stake of 23,064 shares — an estimated $12.3M sold.

Franklin Resources first reported a position in KYNB in Q4 2014 and held it in 6 quarters. The position peaked at $40.9M in Q2 2015. 146 funds tracked by Wall St. Rank hold KYNB as of Q2 2016.

  • Franklin Resources reported no remaining Kyntra Bio position as of Q2 2016 after selling out during the quarter.
  • Franklin Resources sold 23,064 Kyntra Bio shares in Q2 2016, an estimated $12.3M.
  • Franklin Resources first reported a position in Kyntra Bio in Q4 2014 and held it in 6 quarters.
  • Franklin Resources's Kyntra Bio position peaked at $40.9M in Q2 2015.
  • 146 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2016.

Based on Franklin Resources's 13F filing for Q2 2016, filed 11 Aug 2016.